Download Citation
Article Source:
The HCV Non-Nucleoside Inhibitor Tegobuvir Utilizes a Novel Mechanism of Action to Inhibit NS5B Polymerase Function
Hebner CM,
Han B,
Brendza KM,
Nash M,
Sulfab M,
et al.
(2012)
The HCV Non-Nucleoside Inhibitor Tegobuvir Utilizes a Novel Mechanism of Action to Inhibit NS5B Polymerase Function.
PLOS ONE 7(6): e39163.
https://doi.org/10.1371/journal.pone.0039163